Promoter Reporter Vector Services
Inquiry
Aberrant transcriptional regulation is often a key driver of oncogene activation or tumor suppressor gene silencing. Promoter reporter vectors, by driving reporter gene expression under the control of a promoter sequence of interest, provide a critical technology for quantitatively assessing transcriptional activity, mapping regulatory elements, and monitoring signaling pathway status. Alfa Cytology specializes in the construction and optimization of promoter reporter vectors, offering customized, high-quality promoter reporter vectors based on multiple reporter systems including luciferase, GFP/mCherry, and dual-luciferase.
Introduction to Promoter Reporter Vector
Promoter reporter vectors are constructed by cloning the promoter sequence of interest upstream of a reporter gene, whereby the transcriptional activity of the target promoter is indirectly reflected by measuring reporter gene expression. Luciferase is currently the most commonly used reporter gene due to its high sensitivity, broad linear range, and low background; dual-luciferase reporter systems (e.g., firefly luciferase plus Renilla luciferase) significantly improve experimental accuracy and reproducibility by normalizing for transfection efficiency; additionally, fluorescent protein reporters (GFP, mCherry) are suitable for real-time monitoring and cell sorting applications. In cancer research, promoter reporter vectors serve as important tools for dissecting tumor-associated transcriptional regulatory networks and are widely applied in transcription factor activity detection, oncogenic signaling pathway analysis, anti-tumor drug screening, and gene expression regulation studies. Depending on research objectives, promoter reporter vectors can be used to assess the transcriptional activation capacity of specific transcription factors in cancer cells, monitor the activation status of oncogenic signaling pathways (e.g., NF-κB and AP-1 response element reporter vectors), evaluate the effects of anti-tumor drugs on promoter activity, or identify key cis-acting elements and transcription factor binding sites driving tumorigenesis through promoter truncation and mutation series.
Fig. 1 Establishment of different-length RASSF1A promoter luciferase reporter system. (Kang Y, et al.; 2025)
Our Services
Alfa Cytology's Promoter Reporter Vector Services support a variety of reporter genes, vector backbones, and promoter sources, suitable for quantitative detection of transcriptional activity, signaling pathway analysis, and drug screening. Based on your research objectives, we provide end-to-end services from vector design and construction to promoter mutation and regulatory element analysis, facilitating the dissection of tumor transcriptional regulatory mechanisms and anti-tumor drug screening research.
Vector Design and Construction
Based on your research objectives, we design and construct reporter gene vectors carrying the promoter sequence of interest. Services include:
- PCR amplification and cloning of the target promoter sequence (from genomic DNA or client-provided template).
- Construction of promoter truncation series (for cis-acting element mapping).
- Selection of multiple reporter genes: luciferase, GFP / mCherry, dual-luciferase system.
- Multiple vector backbones: pGL3 series, pGL4 series, pLVX series (lentiviral), etc.
- Full-length sequencing verification to ensure 100% accuracy of the inserted sequence.
Promoter Mutation and Regulatory Element Analysis
For studies on promoter regulatory mechanisms, we offer the following services:
- Prediction and mutation analysis of transcription factor binding sites.
- Construction of promoter truncation and deletion mutation series.
- Site-directed mutagenesis (mutation of transcription factor binding sites).
Available Vector Types
| Vector Type |
Features |
Best-fit Applications |
| Standard reporter vector |
Classical transient detection, short turnaround time, high sensitivity |
Rapid assessment of promoter activity, detection of transcription factor activity |
| Lentiviral reporter vector |
Genomic integration, long-term stable expression |
Establishment of stably transfected reporter cell lines, long-term tracking studies |
| Dual-luciferase vector |
Includes internal control for normalization, accurate data |
Experiments requiring precise normalization, high-throughput screening |
Specifications
| Parameter |
Specification |
| Reporter genes |
Luciferase, GFP/mCherry, dual-luciferase (firefly + Renilla) |
| Vector backbones |
pGL3-Basic, pGL4 series, pLVX-Luc, pAAV-Luc, etc. |
| Promoter source |
Client-provided sequence / genomic amplification / synthesis |
| Selection markers |
Puromycin, Neomycin (optional) |
| Delivery format |
Plasmid DNA, glycerol stocks, sequencing reports |
| Detection support |
Luciferase activity assay (optional) |
| Turnaround time |
2–3 weeks |
Applications of Promoter Reporter Vector Services

Transcription Factor Activity Detection
Construct reporter vectors containing transcription factor binding sites to detect the transcriptional activation capacity of specific transcription factors in tumors and evaluate their regulatory effects on downstream target genes.

Signaling Pathway Analysis
Construct reporter vectors containing pathway response elements (e.g., NF-κB, AP-1, STAT3) to monitor the activation status of signaling pathways and assess the effects of drugs or genetic perturbations on pathway activity.

Promoter Regulatory Mechanism Studies
Identify key regulatory regions and transcription factor binding sites through promoter truncation and site-directed mutagenesis analysis, revealing the molecular mechanisms underlying promoter activity regulation.

Functional Dissection of Non-Coding Regions
Construct reporter vectors for non-coding regions (enhancers, silencers, etc.) to evaluate their functional activity in gene transcriptional regulation.

miRNA Target Validation
Construct reporter vectors containing miRNA binding sites and validate the regulatory relationship between miRNAs and the 3′ UTR of target genes by detecting changes in reporter gene expression.

Drug Screening and Efficacy Evaluation
Establish reporter gene-based high-throughput screening systems to screen pathway agonists or inhibitors and evaluate the regulatory effects of candidate drugs on signaling pathways and gene transcription.
Workflow of Promoter Reporter Vector Services
Project Consultation and Strategy Design
Our scientific team communicates closely with you to understand your research objectives, promoter information, cell type, and detection requirements, and designs the optimal reporter vector construction strategy.
Vector Design and Construction
Based on the approved plan, promoter sequence PCR amplification, cloning into the reporter vector, reporter gene selection, and vector construction are performed, followed by full-length Sanger sequencing verification.
Promoter Activity Detection (Optional)
The constructed reporter vector is transfected into target cells, and promoter activity is assessed by luciferase activity assay or fluorescence detection to validate vector functionality.
Delivery and Downstream Application Support
Reporter plasmids, glycerol stocks, and complete validation reports are delivered. If stable reporter cell line construction, high-throughput screening, or in vivo imaging studies are required, seamless integration with the corresponding service platforms can be provided.
Service Highlights
Diverse Reporter Systems and Flexible Vector Backbones
Choose from luciferase, GFP/mCherry, and dual-luciferase reporter systems, with multiple backbone options including pGL3, pGL4, pLVX (lentiviral), and pAAV.
End-to-End Service with Rigorous Quality Control
From promoter sequence amplification and vector construction to promoter mutation and regulatory element analysis, every construct undergoes full-length Sanger sequencing validation to ensure 100% insert accuracy.
Seamless Downstream Integration and Expert Support
We support stable reporter cell line generation, high-throughput screening, and in vivo imaging studies, backed by our advanced reporter vector construction platform and experienced scientific team.
Alfa Cytology combines an advanced promoter reporter vector platform with rigorous project management and exceptional scientific expertise. Whether you need to quantify transcriptional activity, map key regulatory elements, or build a high-throughput screening system, we are your trusted partner for accelerating cancer research. Please feel free to contact us to discuss your project.
Reference
- Kang Y, et al. Transcriptional regulation of tumor suppressor gene RASSF1A by HBx. Mol Cell Probes. 2025;82:102034.
For research use only.
Related Services